NanoEcho AB (publ) (STO:NANECH)
Sweden · Delayed Price · Currency is SEK 0.0272
-0.0020 (-6.85%)
At close: Sep 3, 2026
NanoEcho AB Revenue
NanoEcho AB had revenue of 706.00K SEK in the quarter ending June 30, 2026, with 216.59% growth. This brings the company's revenue in the last twelve months to 2.27M, down -75.75% year-over-year. In the year 2025, NanoEcho AB had annual revenue of 1.63M, down -78.84%.
Revenue (ttm)
2.27M
Revenue Growth
-75.75%
P/S Ratio
11.00
Revenue / Employee
226.20K
Employees
5
Market Cap
12.45M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.63M | -6.06M | -78.84% |
| Dec 31, 2024 | 7.68M | 5.24M | 214.88% |
| Dec 31, 2023 | 2.44M | 20.00K | 0.83% |
| Dec 31, 2022 | 2.42M | 2.10M | 649.68% |
| Dec 31, 2021 | 322.67K | 321.67K | 32,167.30% |
| Dec 31, 2020 | 1.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 275.79M |
| ExpreS2ion Biotech Holding AB | 24.25M |
| Fluicell AB | 22.19M |
| AcouSort AB | 9.31M |
| OncoZenge AB | 5.97M |
| Biosergen AB | 2.09M |
| Alligator Bioscience AB | 681.00K |
| Pila Pharma AB | 275.74K |
NanoEcho AB News
- 10 days ago - NanoEcho AB Quarterly report: Q2 2026 - Filings
- 4 months ago - NanoEcho AB Quarterly report: Q1 2026 - Filings
- 6 months ago - NanoEcho AB Annual report: Q4 2025 - Filings
- 6 months ago - NanoEcho AB Quarterly report: Q4 2025 - Filings
- 10 months ago - NanoEcho AB Quarterly report: Q3 2025 - Filings